| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8433351 | Cancer Epidemiology | 2016 | 6 Pages |
Abstract
No changes were observed in the relative contribution of HPV types in cervical cancer in Cali, Colombia during the 50 years. In this population, an HPV vaccine including the HPV 16, 18, 31, 33, 45, 52 and 58 genotypes may have the potential to prevent â¼85% and 93% of SCC and ADC cases respectively.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Gloria Ines Sanchez, Luis Eduardo Bravo, Gustavo Hernandez-Suarez, Sara Tous, Laia Alemany, Silvia de Sanjose, F. Xavier Bosch, Nubia Muñoz,